Medikit

Basic Information

Stock Code
7749
Industry
Precision Instruments
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Tokyo
Establishment Year
June 1973
Listing Year
June 2005
Official Website
https://www.medikit.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Hogi Medical, Create Medic, Toami, Kikukawa, Hoshi Medical, JMS, Manny, Asahi Intecc, Daiken Iki, Matsufuji, Nipro

Overview

Medikit is a medical device manufacturer founded in 1973, boasting the top domestic market share for hemodialysis catheters and providing high-quality products through its proprietary fluororesin processing technology.

Current Situation

As of 2024, Medikit has achieved consolidated sales of approximately 26.5 billion yen and maintains the top domestic market share in medical vascular catheters. Centered on its main subsidiary Togo Medikit, it develops a diverse product lineup including angiography and infusion catheters, focusing on quality and technological innovation. Fluororesin processing technology provides a clear differentiation from competitors and has earned high trust. In recent years, it has improved production efficiency and explored overseas markets, establishing a stable growth base. It promotes sustainable medical device development, emphasizing enhanced safety and reduced environmental impact. In the future, it aims to expand its business through AI/IoT utilization and new medical device development. Notable trends include subsidiary investment plans and shareholder returns via treasury stock cancellation.

Trivia

Interesting Facts

  • Developer of Japan's first fluororesin integrated vascular indwelling needle
  • Maintains top domestic share in hemodialysis catheters
  • Possesses proprietary technology using skin-friendly materials
  • Contributing deeply to medical sites since its founding in 1973
  • Subsidiary Togo Medikit specializes in manufacturing with strong collaboration
  • Owns multiple factories in Miyazaki Prefecture, contributing to local economy
  • Founder Hiroaki Nakajima known as an industry pioneer
  • Actively implements shareholder returns through treasury stock cancellation
  • Established high-quality assurance system in medical device manufacturing
  • Advancing overseas expansion with products compliant to international standards

Hidden Connections

  • Sponsors local soccer team 'Tegevajaro Miyazaki' to contribute to regional revitalization
  • Collaborates with universities for long-term talent development in medical technology
  • Promoting joint development of new medical materials applying catheter technology
  • Major shareholder Nakajima Corporation provides stable management base
  • Efficient supply chain built between manufacturing sites in Miyazaki and Chiba
  • Gains high evaluation from domestic and international medical institutions for eco-friendly materials
  • Actively participates as a company in medical device standardization activities
  • Jointly owns patents for new material technology with multiple firms in the medical device industry

Future Outlook

Growth Drivers

  • Increased demand for high-quality products due to advanced medical devices and stricter safety regulations
  • Growing number of hemodialysis patients domestically and internationally
  • Enhanced competitiveness and expanded applications of fluororesin processing technology
  • Expansion of overseas medical device markets and business advancement
  • Manufacturing and quality management innovations through AI/IoT utilization
  • Rising demand for sustainable medical devices and environmental compliance
  • Needs from new medical facility openings and improved medical service quality
  • Market differentiation through introduction of new products and material technologies
  • Market superiority through prompt compliance with medical regulations
  • Strengthened product lineup through integrated operations with subsidiaries
  • Expanding coverage from acute care to home medical care
  • Investment promotion through shareholder return policies and strengthened financial position

Strategic Goals

  • Secure over 55% share in domestic medical catheter market
  • Achieve 30% overseas sales ratio and expand into new countries
  • Expand and diversify product lineup by more than 20%
  • Complete introduction of AI/IoT technology across all production processes
  • Expand sustainable certified products to 40%
  • Achieve 30% reduction target in environmental impact from manufacturing sites
  • Nationwide rollout of medical material recycling systems
  • Increase mid- to long-term R&D expenses by 15% by 2025
  • Establish leadership in medical device R&D
  • Strengthen technological capabilities through in-house talent development programs

Business Segments

Catheter Supply to Medical Institutions

Overview
Business area for stable supply of catheters needed for surgery, dialysis, and examinations.
Competitiveness
High-quality product provision through fluororesin processing technology
Customers
  • Hospitals
  • Clinics
  • Dialysis Centers
  • Medical Offices
  • Medical Device Distributors
Products
  • Dialysis Indwelling Needle
  • Angiography Catheter
  • Infusion Catheter
  • Sheath Introducer
  • Safe Indwelling Needle Set

Medical Device OEM Manufacturing

Overview
High-quality OEM manufacturing services for domestic and international manufacturers.
Competitiveness
Established manufacturing technology and quality control
Customers
  • Other Medical Device Manufacturers
  • Medical Device Distributors
  • Medical Equipment Exporters
Products
  • Vascular Catheters
  • Indwelling Needles
  • Infusion-Related Devices

Medical Supplies Export

Overview
Exports high-reliability products to overseas markets.
Competitiveness
Product lineup compliant with international standards
Customers
  • Overseas Medical Institutions
  • Medical Device Importers
Products
  • Catheter Products
  • Medical Indwelling Needles

R&D and Technology Provision

Overview
Support for new medical device development and technology licensing.
Competitiveness
Proprietary technology and know-how
Customers
  • Medical Institutions
  • University Research Institutes
  • Industry-Academia Collaboration Projects
Products
  • Fluororesin Processing Technology
  • Vascular Device Design
  • Custom Medical Devices

Medical Accessory Manufacturing

Overview
Manufacturing of consumables and parts that complement medical devices.
Competitiveness
High-quality accessory product lineup
Customers
  • Medical Device Distributors
  • Medical Institutions
Products
  • Fixation Tape
  • Valves & Connectors

Competitive Advantage

Strengths

  • Top domestic share in hemodialysis catheters
  • Advanced fluororesin integrated processing technology
  • High-quality product design and manufacturing management
  • Strong subsidiary structure with Togo Medikit
  • Stable financial base and shareholder composition
  • Handling of diverse medical supplies
  • Comprehensive manufacturing sites and logistics network
  • Long track record of trust in the medical industry
  • Product compliance with international standards
  • Steadfast R&D approach
  • Prompt customer response and technical support
  • Diversified sales channels domestically and internationally
  • Design philosophy emphasizing safety
  • Active shareholder return measures
  • Product lineup expansion through subsidiary collaboration

Competitive Advantages

  • Fluororesin integrated molding technology provides uniqueness not found in competitors
  • Secures stable demand with top domestic share in hemodialysis-related products
  • Optimizes development and manufacturing through integrated operation with Togo Medikit subsidiary
  • High-quality management system earns strong trust from medical institutions
  • Diverse product lineup meets wide range of customer needs
  • Efficiently operates sales networks domestically and internationally
  • Implements proactive shareholder value enhancement via treasury stock cancellation
  • Engages in sustainable product development responsive to safety regulations
  • Succeeds in production cost reduction and product quality improvement through new technology introduction
  • Establishes rapid technological innovation process in collaboration with subsidiaries
  • Strong compliance with medical industry regulations supports stable supply
  • Diversifies revenue sources by accommodating diverse customers in OEM business
  • Actively pursues growth opportunities in overseas markets through exports
  • Builds close customer relationships and leverages feedback into products
  • Enables sustained strengthening of technology through long-term talent development

Threats

  • Development and approval delays due to stricter medical device regulations
  • Increase in low-price products from competing firms
  • Market share erosion from technological innovations by overseas manufacturers
  • Destabilization of export price competitiveness due to exchange rate fluctuations
  • Intensified price competition from medical institutions' cost-cutting pressures
  • Risks of raw material shortages and price fluctuations
  • Local regulations and political risks in emerging markets
  • Risk of obsolescence of existing products due to technological advancements
  • Demand instability from social changes like new infectious diseases
  • Legal risks related to patent infringement and intellectual property
  • Impact on production systems from labor shortages
  • Rising production costs due to strengthened environmental regulations

Innovations

2024: Introduction of Production Line Automation

Overview
Introduced the latest robot technology to significantly improve production efficiency.
Impact
20% increase in production capacity, 15% cost reduction

2023: Development of New Fluororesin Processing Technology

Overview
Established more flexible material processing technology to enhance product safety.
Impact
Enhanced product competitiveness and customer satisfaction

2022: Togo Medikit New Factory Construction

Overview
Built a factory with the latest equipment to strengthen the production base.
Impact
Increased production volume and reinforced stable supply system

2021: Introduction of AI Inspection Technology

Overview
Utilized AI in manufacturing quality inspections to reduce defect rates.
Impact
10% reduction in defect rate, improved production efficiency

2020: Expansion of Environmentally Friendly Materials

Overview
Promoted use of recyclable materials to reduce environmental impact.
Impact
Expanded lineup of environmentally considerate products

Sustainability

  • Manufacturing process improvements to reduce environmental impact
  • Promotion of medical waste recycling activities
  • Introduction of energy-efficient equipment
  • Participation in environmental conservation projects with local communities
  • Introduction of sustainability assessments in the supply chain
  • Implementation of enhanced employee environmental education programs
  • Active adoption of low-carbon emission raw materials
  • Maintenance and updating of ISO 14001 environmental management system
  • Strengthening of health and safety management systems
  • Promotion of product longevity and maintenance services
  • Packaging reforms to reduce plastic usage
  • Social contribution activities and environmental awareness promotion